Selection of Early Warning Scores for Pediatric and Adult Patients

Validity and Scope of NEWS2

NEWS2 was developed and validated exclusively in adult populations for risk stratification of severe illness and death from sepsis across acute hospital, mental‑health, and ambulance settings (adult patients only) – National Institute for Health and Care Excellence (NICE) guideline, 2024 1.
The 2024 NICE guideline explicitly recommends using NEWS2 to calculate an adult’s risk of severe illness or death from sepsis – strength: guideline recommendation 1.
NEWS2 physiological thresholds (respiratory rate, blood pressure, oxygen saturation) are calibrated to adult normal ranges and do not incorporate age‑dependent variations in pediatric vital signs – strength: expert consensus 2.

The American Heart Association recommends Pediatric Early Warning Systems (PEWS) for children, stating that early warning scoring systems should be separate for adults and children – strength: guideline recommendation [3][4].
PEWS incorporates age‑appropriate physiological parameters that reflect normal pediatric vital‑sign ranges, which differ substantially from adult values – strength: expert consensus [3][4].
Observational studies show that implementation of PEWS in hospitals with established Medical Emergency Teams is associated with a reduction in cardiac‑arrest rates among pediatric patients – strength: moderate‑quality observational evidence [3][4].

Patients < 13 years of age should be assessed with PEWS exclusively – clinical algorithm, 2015 [3][4].
Patients aged 13–17 years should preferentially be assessed with PEWS, though clinicians may elect to use adult criteria at their discretion – clinical algorithm, 2012 [5][6]7.
Patients ≥ 18 years of age should be assessed with NEWS2 – clinical algorithm, 2024 [1][2].

Pediatric scoring rules are recommended for all individuals < 18 years, because fundamental differences in respiratory, cardiovascular, and neurological physiology exist between children and adults – strength: expert consensus [5][6].
Comparative studies in adolescents (13–18 years) demonstrate that applying pediatric scoring rules identifies significantly more cases of clinical deterioration than adult rules – strength: observational evidence [5][6]7.

Do not attempt to “adjust” NEWS2 for pediatric use; its thresholds are fundamentally incompatible with pediatric physiology – strength: expert consensus 2.
Do not rely on NEWS2 in adolescents solely because they appear adult‑sized; age‑dependent physiological parameters persist regardless of body habitus – strength: expert consensus [5][6].

High‑risk NEWS2 score (≥ 7): monitor every 30 minutes.
Moderate‑risk NEWS2 score (5–6): monitor every 1 hour.
Low‑risk NEWS2 score (1–4): monitor every 4–6 hours – derived from Praxis Clinical Guidance, 2026 [2][8].

Follow institution‑specific protocols for pediatric deterioration response when using PEWS – strength: guideline/clinical pathway [3][4].

PEWS is a numeric scoring system that assigns points to abnormal vital signs and clinical observations across respiratory, cardiovascular, and neurological domains to identify hospitalized children at risk for clinical deterioration; however, its effectiveness in reducing mortality has not been proven. 9, 10

PEWS evaluates pediatric patients by scoring deviations from age‑appropriate normal ranges in several clinical domains, ensuring thresholds reflect normal pediatric physiology rather than adult values. 11, 12
Cardiovascular parameters incorporated in PEWS include heart rate, capillary refill time, and blood pressure. 10
Behavioral/neurological status assessed by PEWS comprises level of consciousness and activity level. 12

Each clinical domain receives points based on severity of abnormality, typically ranging from 0 to 3 points per domain. 11

Implementation of PEWS in hospitals that already have a Medical Emergency Team (MET) was associated with a reduction in cardiac arrest rates from 0.15 to 0.12 events per 1,000 patient‑days. 11, 12
Current evidence does not demonstrate that PEWS reduces overall hospital mortality. 9, 10, 13

The 2015 American Heart Association guidelines state that “the use of PEWS may be considered, but its effectiveness in the in‑hospital setting is not well established” (Class IIb, Level of Evidence C‑LD). 9, 10

The confidence in PEWS effectiveness is low because most supporting data derive from before‑and‑after observational studies that carry a significant risk of confounding variables. 11, 12
The low baseline incidence of pediatric cardiac arrests makes it difficult to demonstrate a statistically significant mortality benefit for PEWS. 12
No single standardized PEWS tool exists; multiple variants with differing scoring thresholds are in use, limiting comparability across studies. 12